# Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)

> **NCT06103669** · NA · RECRUITING · sponsor: **University of California, Davis** · enrollment: 250 (estimated)

## Conditions studied

- Breast Cancer
- Oligoprogressive
- Head and Neck Cancer
- Sarcoma
- Other Cancer

## Interventions

- **DEVICE:** Ablative local therapy

## Key facts

- **NCT ID:** NCT06103669
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-05
- **Primary completion:** 2025-12-05
- **Final completion:** 2031-01-05
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06103669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06103669, "Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06103669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*